Author:
Ursini-Siegel J,Hardy W R,Zheng Y,Ling C,Zuo D,Zhang C,Podmore L,Pawson T,Muller W J
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference45 articles.
1. Frackelton Jr AR, Lu L, Davol PA, Bagdasaryan R, Hafer LJ, Sgroi DC . p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy. Breast Cancer Res 2006; 8: R73.
2. Davol PA, Bagdasaryan R, Elfenbein GJ, Maizel AL, Frackelton Jr AR . Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer. Cancer Res 2003; 63: 6772–6783.
3. Ursini-Siegel J, Cory S, Zuo D, Hardy WR, Rexhepaj E, Lam S et al. Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response. Cancer Res 2010; 70: 7776–7787.
4. Ursini-Siegel J, Hardy WR, Zuo D, Lam SH, Sanguin-Gendreau V, Cardiff RD et al. ShcA signalling is essential for tumour progression in mouse models of human breast cancer. EMBO J 2008; 27: 910–920.
5. Alimandi M, Romano A, Curia MC, Muraro R, Fedi P, Aaronson SA et al. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene 1995; 10: 1813–1821.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献